Page last updated: 2024-11-06

prednisolone and Lewy Body Disease

prednisolone has been researched along with Lewy Body Disease in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Lewy Body Disease: A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikawa, F1
Sumi, N1
Nishikawa, T1
Maruyama, H1
Miyachi, T1

Other Studies

1 other study available for prednisolone and Lewy Body Disease

ArticleYear
[A case of dementia with Lewy bodies and Hashimoto encephalopathy successfully treated with immunotherapy].
    Rinsho shinkeigaku = Clinical neurology, 2019, Feb-23, Volume: 59, Issue:2

    Topics: Aged; Autoantibodies; Biomarkers; Encephalitis; Female; Hashimoto Disease; Humans; Immunotherapy; Io

2019